|
시장보고서
상품코드
2065144
CRISPR 시장 규모, 점유율, 성장 분석 : 용도별, 기술별, 제품별, 최종사용자별, 지역별 - 업계 예측(2026-2033년)CRISPR Market Size, Share, and Growth Analysis, By Application (Genome Editing, Diagnostics (SHERLOCK )), By Technology (CRISPR-Cas9, CRISPR-Cas12), By Product, By End-User, By Region - Industry Forecast 2026-2033 |
||||||
세계의 CRISPR 시장 규모는 2024년에 38억 2,000만 달러로 평가되며, 2025년 45억 6,000만 달러에서 2033년까지 188억 5,000만 달러로 확대할 전망이며, 예측 기간(2026-2033년)에 CAGR 19.32%로 성장할 것으로 전망되고 있습니다.
전 세계 CRISPR 시장은 유전자 편집 기술의 혁신이 실용적인 치료 및 상업적 용도로 빠르게 적용되고 있는 것이 원동력이 되고 있습니다. 이러한 다양한 시장에는 연구, 임상 치료, 농업, 진단 분야에 걸친 툴, 서비스, 플랫폼 및 최종 용도 애플리케이션이 포함됩니다. 이 시장의 중요성은 질병의 경과를 변화시키는 치료를 촉진하고, 연구개발(R&D) 주기를 단축하며, 획기적인 제품을 출시할 수 있는 능력에 있습니다. 성장을 지원하는 중요한 요인은 과학적 진보를 확장 가능한 솔루션으로 전환하는 임상 검증, 투자자의 자금 지원, 그리고 산업계와의 제휴라는 순환 구조입니다. 임상 시험의 성공은 투자자들의 신뢰를 높여, Vertex사와 CRISPR Therapeutics사와 같은 대규모 제휴로 이어집니다. 이러한 제휴를 통해 플랫폼이 최적화되고 제조 역량이 강화됨에 따라 비용 절감과 규제 당국의 승인 획득을 신속히 추진할 수 있게 됩니다.
세계 CRISPR 시장의 성장 요인
전 세계 CRISPR 시장은 유전성 질환, 암 치료, 바이러스 감염증 등 다양한 치료 분야에서 CRISPR 기술이 급속히 발전함에 따라 인상적인 성장을 달성하고 있습니다. CRISPR의 응용 범위가 확대됨에 따라 툴, 시약, 관련 서비스를 포함한 유전체 편집 분야에서 새로운 기회가 생겨나고 있습니다. 연구자들은 과학적 발견을 실용적인 치료법으로 전환하는 데 점점 더 주력하고 있으며, 제약 회사와 임상 연구자들 사이에서 CRISPR 응용에 대한 관심이 높아지고 있습니다. 이처럼 CRISPR가 전임상 연구 및 중개연구에 도입됨에 따라 전문적인 CRISPR 자원 및 툴에 대한 수요가 더욱 증가하여 시장 성장을 지원하고 있습니다.
세계 CRISPR 시장의 제약 요인
전 세계 CRISPR 시장은 규제 체계와 관련된 불확실성, 생식세포 계통의 편집, 인간에 대한 적용, 그리고 잠재적인 생태계에 미치는 영향에 관한 윤리적 논쟁이 계속되고 있으며, 큰 과제에 직면해 있습니다. 이로 인해 개발자, 투자자, 임상 이해관계자들 사이에 주저함이 생겨, 프로젝트 시작이 지연되거나 상업적 전략이 제한되는 경우가 종종 있습니다. 장기간에 걸친 심사 절차의 복잡성과 변화하는 정책 기대에 적응해야 할 필요성으로 인해 막대한 규정 준수 대응이 요구되며, 이는 파이프라인의 우선순위에 관한 전략적 결정에 영향을 미칠 가능성이 있습니다. 그 결과, 이러한 신중한 분위기는 임상 적용을 위한 제품의 발전을 지연시키고, 특정 분야에 대한 투자 의욕을 저하시킬 뿐만 아니라, 지역별 요건의 차이로 인해 시장의 세분화를 초래할 우려가 있습니다.
세계 CRISPR 시장의 동향
현재 전 세계 CRISPR 시장은 유전자 편집 기술의 정확성과 특이성을 높이는 전달 플랫폼의 발전에 힘입어 혁신적인 변화를 겪고 있습니다. 벡터 설계, 나노입자 화학 및 제형 전략 분야의 혁신을 통해 CRISPR 전달 시스템의 효능이 크게 향상되었으며, 그 결과 오프타겟 효과가 감소하고 적용 가능한 적응증의 범위가 확대되고 있습니다. 이러한 발전은 임상 현장에서의 도입 확대를 촉진하고, 유전자 편집 기업과 전달 기술 전문가 간의 협력을 지원하고 있습니다. 그 결과, 시장의 초점은 핵심 효소 제품에서 통합형 전달 솔루션으로 이동하고 있으며, 이는 보다 효율적인 개발 프로세스를 촉진하고, 치료 및 연구 환경에서의 도입을 가속화하며, 상업적 기회를 확대하고 있습니다.
자주 묻는 질문
목차
서론
조사 방법
개요
시장 역학과 전망
주요 시장 인사이트
세계의 CRISPR 시장 규모 : 용도별
세계의 CRISPR 시장 규모 : 기술별
세계의 CRISPR 시장 규모 : 제품별
세계의 CRISPR 시장 규모 : 최종사용자별
세계의 CRISPR 시장 규모 : 지역별
경쟁 정보
주요 기업 개요
결론과 제안
KSA 26.07.01Global Crispr Market size was valued at USD 3.82 Billion in 2024 and is poised to grow from USD 4.56 Billion in 2025 to USD 18.85 Billion by 2033, growing at a CAGR of 19.32% during the forecast period (2026-2033).
The global CRISPR market is driven by the rapid translation of gene-editing innovations into viable therapeutic and commercial applications. This diverse market includes tools, services, platforms, and end-use applications across research, clinical therapies, agriculture, and diagnostics. The significance of this market lies in its ability to facilitate disease-modifying treatments, shorten R&D cycles, and introduce groundbreaking products. A crucial factor boosting growth is the cycle of clinical validation, investor funding, and industrial partnerships that transform scientific advancements into scalable solutions. Successful clinical trials build investor confidence, leading to larger collaborations like those between Vertex and CRISPR Therapeutics, which optimize platforms and enhance manufacturing capabilities, thereby reducing costs and expediting regulatory approvals.
Top-down and bottom-up approaches were used to estimate and validate the size of the Global Crispr market and to estimate the size of various other dependent submarkets. The research methodology used to estimate the market size includes the following details: The key players in the market were identified through secondary research, and their market shares in the respective regions were determined through primary and secondary research. This entire procedure includes the study of the annual and financial reports of the top market players and extensive interviews for key insights from industry leaders such as CEOs, VPs, directors, and marketing executives. All percentage shares split, and breakdowns were determined using secondary sources and verified through Primary sources. All possible parameters that affect the markets covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data.
Global Crispr Market Segments Analysis
Global CRISPR market is segmented by application, technology, product, end-user and region. Based on application, the market is segmented into Genome Editing, Diagnostics (SHERLOCK, DETECTR), Agricultural Biotechnology and Drug Development. Based on technology, the market is segmented into CRISPR-Cas9, CRISPR-Cas12, Base Editing and Prime Editing. Based on product, the market is segmented into Instruments, Reagents & Kits and Services. Based on end-user, the market is segmented into Pharma & Biotech, Research Institutes, Agri-Biotech and Clinical Diagnostics. Based on region, the market is segmented into North America, Europe, Asia Pacific, Latin America and Middle East & Africa.
Driver of the Global Crispr Market
The global CRISPR market is experiencing significant growth driven by the rapid evolution of CRISPR technologies across various therapeutic fields, including genetic disorders, cancer treatment, and viral infections. As the application of CRISPR expands, it is fostering new opportunities within the genome editing domain, encompassing tools, reagents, and associated services. Researchers are increasingly focused on translating scientific discoveries into viable treatments, prompting heightened interest from pharmaceutical companies and clinical researchers in CRISPR applications. This integration of CRISPR into preclinical and translational research further amplifies the demand for specialized CRISPR resources and tools, thereby propelling the growth of the market.
Restraints in the Global Crispr Market
The global CRISPR market faces significant challenges due to uncertainty surrounding regulatory frameworks and ongoing ethical discussions related to germline editing, human applications, and potential ecological impacts. This creates hesitation among developers, investors, and clinical stakeholders, often resulting in delays for project initiation and restricting commercial strategies. The complexity of lengthy review processes and the need to adapt to changing policy expectations necessitate substantial compliance efforts, which can shape strategic decisions regarding pipeline priorities. Consequently, this cautious atmosphere slows down the advancement of products toward clinical applications, diminishes investment interest in specific areas, and may lead to a fragmented market due to varying requirements across regions.
Market Trends of the Global Crispr Market
The Global CRISPR market is currently witnessing a transformative shift driven by advancements in delivery platforms that enhance the precision and specificity of gene editing technologies. Innovations in vector design, nanoparticle chemistry, and formulation strategies are significantly improving the effectiveness of CRISPR delivery systems, thereby reducing off-target effects and widening the spectrum of applicable indications. This evolution is fostering increased clinical adoption and encouraging collaborations between gene editing firms and delivery technology specialists. Consequently, the market's focus is transitioning from core enzyme products to integrated delivery solutions, promoting more efficient development processes, expediting adoption in therapeutic and research environments, and boosting commercial opportunities.
Table of Contents
Introduction
- Objectives of the Study
- Market Definition & Scope
Research Methodology
- Research Process
- Secondary & Primary Data Methods
- Market Size Estimation Methods
Executive Summary
- Global Market Outlook
- Key Market Highlights
- Segmental Overview
- Competition Overview
Market Dynamics & Outlook
- Macro-Economic Indicators
- Drivers & Opportunities
- Restraints & Challenges
- Supply Side Trends
- Demand Side Trends
- Porters Analysis & Impact
- Competitive Rivalry
- Threat of Substitute
- Bargaining Power of Buyers
- Threat of New Entrants
- Bargaining Power of Suppliers
Key Market Insights
- Key Success Factors
- Market Impacting Factors
- Top Investment Pockets
- Ecosystem Mapping
- Market Attractiveness Index 2025
- PESTEL Analysis
- Regulatory Landscape
Global CRISPR Market Size by Application & CAGR (2026-2033)
- Market Overview
- Genome Editing
- Diagnostics (SHERLOCK, DETECTR)
- Agricultural Biotechnology
- Drug Development
Global CRISPR Market Size by Technology & CAGR (2026-2033)
- Market Overview
- CRISPR-Cas9
- CRISPR-Cas12
- Base Editing
- Prime Editing
Global CRISPR Market Size by Product & CAGR (2026-2033)
- Market Overview
- Instruments
- Reagents & Kits
- Services
Global CRISPR Market Size by End-User & CAGR (2026-2033)
- Market Overview
- Pharma & Biotech
- Research Institutes
- Agri-Biotech
- Clinical Diagnostics
Global CRISPR Market Size & CAGR (2026-2033)
- North America (Application, Technology, Product, End-User)
- US
- Canada
- Europe (Application, Technology, Product, End-User)
- Germany
- Spain
- France
- UK
- Italy
- Rest of Europe
- Asia Pacific (Application, Technology, Product, End-User)
- China
- India
- Japan
- South Korea
- Rest of Asia-Pacific
- Latin America (Application, Technology, Product, End-User)
- Mexico
- Brazil
- Rest of Latin America
- Middle East & Africa (Application, Technology, Product, End-User)
- GCC Countries
- South Africa
- Rest of Middle East & Africa
Competitive Intelligence
- Top 5 Player Comparison
- Market Positioning of Key Players, 2025
- Strategies Adopted by Key Market Players
- Recent Developments in the Market
- Company Market Share Analysis, 2025
- Company Profiles of All Key Players
- Company Details
- Product Portfolio Analysis
- Company's Segmental Share Analysis
- Revenue Y-O-Y Comparison (2023-2025)
Key Company Profiles
- Editas Medicine
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- Intellia Therapeutics
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- CRISPR Therapeutics
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- Beam Therapeutics
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- Prime Medicine
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- Caribou Biosciences
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- Inscripta Inc.
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- Arbor Biotechnologies
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- Sherlock Biosciences
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- Mammoth Biosciences
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- ERS Genomics
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- Horizon Discovery (PerkinElmer)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- GenScript Biotech
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- Synthego Corporation
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- Integrated DNA Technologies
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- Addgene
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- Cellectis SA
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- Precision BioSciences
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- Sangamo Therapeutics
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- Agilent Technologies
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
